Deutsche Bank rep fined $5,000 for role in outside medical marijuana business

Deutsche Bank rep fined $5,000 for role in outside medical marijuana business
Finra also suspends Mina Mishrikey for three months
APR 13, 2018
Finra has fined Mina Mishrikey $5,000 and suspended him for three months because he continued to participate in a medical marijuana business after his firm told him not to. The Financial Industry Regulatory Authority Inc. said that in September 2016, Mr. Mishrikey sought approval from Deutsche Bank, his employer, to participate in a company that intended to submit a license to the Commonwealth of Pennsylvania to produce and sell medical marijuana pursuant to the state's medical marijuana law. Although the firm denied his request, Mr. Mishrikey continued to work as a director of the company through July 2017, Finra said in its letter of acceptance, waiver and consent. He also failed to notify Deutsche Bank that he had continued to participate in the prohibited outside business activity and initially denied that he was doing so when his firm confronted him. (More: Rogue brokers still pose a danger to investors)

Latest News

Stratos Wealth Holdings closes 11 acquisitions in push for advisory scale
Stratos Wealth Holdings closes 11 acquisitions in push for advisory scale

RIA aggregator adds $4.8 billion in client assets across seven states as demand grows for alternatives to traditional succession models.

Beyond wealth management: Why the future of advice is becoming more human
Beyond wealth management: Why the future of advice is becoming more human

As technical expertise becomes increasingly commoditized, advisors who can integrate strategy, relationships, and specialized expertise into a cohesive client experience will define the next era of wealth management

Shareholder sues FS KKR Capital board, alleges NAV and dividend cover-up
Shareholder sues FS KKR Capital board, alleges NAV and dividend cover-up

Shareholder targets FS KKR Capital's directors over alleged portfolio valuation and dividend missteps.

UBS loses $1.2 million arbitration claim linked to variable annuities and margin
UBS loses $1.2 million arbitration claim linked to variable annuities and margin

UBS has a history of costly litigation stemming from the sale of volatile investment products.

'We are monitoring the situation,' SEC says of private funds
'We are monitoring the situation,' SEC says of private funds

New director David Woodcock puts firms on notice over fees, conflicts, and liquidity risk as private credit shows signs of stress.

SPONSORED Beyond wealth management: Why the future of advice is becoming more human

As technical expertise becomes increasingly commoditized, advisors who can integrate strategy, relationships, and specialized expertise into a cohesive client experience will define the next era of wealth management

SPONSORED Durability over scale: What actually defines a great advisory firm

Growth may get the headlines, but in my experience, longevity is earned through structure, culture, and discipline